Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome–positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation
Considering previous reports that showed inferior outcomes for de novo CML-BP compared to Ph-positive ALL, the data suggested that allogeneic HCT could overcome the poor prognosis of de novo CML-BP. These findings highlight the importance of distinguishing de novo CML-BP from Ph-positive ALL.
Authors
- Masatsugu Tanaka (ORCID: https://orcid.org/0000-0001-8814-230X)
- Noriaki Tachi
- Naoyuki Uchida (ORCID: https://orcid.org/0000-0001-5952-5926)
- Yoshinobu Kanda (ORCID: https://orcid.org/0000-0002-4866-9307)
- Yuta Hasegawa (ORCID: https://orcid.org/0000-0002-9925-2093)
- Masako Toyosaki (ORCID: https://orcid.org/0009-0008-6455-3831)
- Makoto Murata (ORCID: https://orcid.org/0000-0001-5488-4364)
- Yosuke Okada (ORCID: https://orcid.org/0000-0003-4998-9078)
- Takayoshi Tachibana (ORCID: https://orcid.org/0000-0002-7780-4459)
- Tetsuya Nishida
- Yoshiko Atsuta (ORCID: https://orcid.org/0000-0003-4404-2870)
- Shinichi Kako (ORCID: https://orcid.org/0000-0002-2635-3395)
- Atsushi Jinguji
- Makoto Onizuka (ORCID: https://orcid.org/0000-0003-3864-0823)
- Satoshi Nishiwaki (ORCID: https://orcid.org/0000-0002-6430-8958)
- Yasushi Onishi (ORCID: https://orcid.org/0000-0003-0032-6994)
- Hirohisa Nakamae (ORCID: https://orcid.org/0000-0003-4203-990X)
- Yutaka Shimazu (ORCID: https://orcid.org/0000-0002-1604-7220)
- Yasuyuki Arai (ORCID: https://orcid.org/0000-0002-9662-5093)
- Ayumu Ito (ORCID: https://orcid.org/0000-0001-5681-6357)
- Marie Ohbiki (ORCID: https://orcid.org/0009-0007-3522-2278)
- Masashi Sawa
- Takahiro Fukuda
- Koichi Onodera
Institutions
- Tokai University (JP)
- Jichi Medical University (JP)
- Shiga University of Medical Science (JP)
- Aichi Medical University (JP)
- Kyoto University (JP)
- Kanagawa Prefectural Hospital Organization (JP)
- Tokyo Metropolitan Komagome Hospital (JP)
- National Defense Medical College Hospital (JP)
- Nagoya University Hospital (JP)
- Tohoku University Hospital (JP)
- Japanese Red Cross Nagoya Daiichi Hospital (JP)
- Hokkaido University Hospital (JP)
- Anjo Kosei Hospital (JP)
- Kyoto University Hospital (JP)
- The Japanese Data Center for Hematopoietic Cell Transplantation (JP)
- Osaka City University Hospital (JP)
- Jichi Medical University Saitama Medical Center (JP)
- Toranomon Hospital (JP)
- Kanagawa Cancer Center
- Osaka Metropolitan University (JP)
- National Defense Medical College (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Cancer
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1002/cncr.35627
- Citations
- 1
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Bristol-Myers Squibb